Heart Failure
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Information is based on current medical literature and clinical guidelines but may not apply to your specific situation. Individual responses vary based on personal medical history and concurrent conditions. Always consult qualified healthcare providers before starting new treatments and for all medical decisions. Never delay seeking medical care based on content you have read.
These articles provide education to enhance your healthcare partnership. All treatment decisions should involve your healthcare team. Use this knowledge to have informed discussions, not replace medical care.
In Brief
There is no single test that says “heart failure.” It is a clinical diagnosis — a conclusion a clinician reaches by fitting together the story a person tells, the findings on examination, a blood test, and a picture of the heart. Two tests carry most of the weight: a blood test called the natriuretic peptide, which measures a hormone the strained heart releases, and the echocardiogram, an ultrasound that shows the heart pumping and gives the ejection fraction. Each answers a different question, and — just as importantly — each has blind spots. The blood test can read falsely low in people carrying extra weight, exactly where heart failure is easy to miss. The ejection fraction sorts heart failure into the categories that guide treatment, but a normal value never rules the condition out. This article explains what each test reveals, what it cannot, and why confirming heart failure is only half the job — the other half is finding out why.
No Single Test Says “Heart Failure”
A note before the details: this article describes how heart failure is evaluated in the usual, unhurried way. Severe or rapidly worsening breathlessness, fainting, new chest pressure or pain, confusion, or other signs of acute illness call for prompt medical evaluation rather than waiting for an outpatient workup.
People often expect a diagnosis to come from one definitive test. Heart failure does not work that way, and understanding why makes the rest of this article clearer.
The organizations that define heart failure describe it as a clinical syndrome: a pattern of symptoms and physical signs, arising from a structural or functional problem with the heart, and confirmed by objective evidence — a raised blood marker, or imaging showing congestion or abnormal heart structure and pressures.[1] No one piece proves it alone. The symptoms are shared with many other conditions; the blood test can be raised or lowered by things that have nothing to do with the heart; the ultrasound can look near-normal in a failing heart. Diagnosis is the convergence of these strands, weighed together by someone who knows how each can mislead.
That is not a weakness in the process. It is the reason a good workup uses several tests at once — each covering the others’ blind spots.
It is also why the workup has to rule things in and out. Breathlessness and swelling have many causes — lung disease, kidney disease, obesity, and simple deconditioning among them — and several of these can mimic heart failure closely.[1] Part of the evaluation is telling heart failure apart from these look-alikes, which is another reason it leans on objective tests rather than symptoms alone.
What the Tests Are Trying to Answer
It helps to see the workup not as a list of tests but as a set of questions. A heart-failure evaluation is working through four of them, roughly in order:
- Is heart failure present at all? — answered mainly by the clinical picture, the natriuretic peptide, and the echocardiogram.
- What type of heart failure is it? — the echocardiogram defines the ejection-fraction pattern and also evaluates chamber structure, the valves, right-heart function, and evidence of abnormal filling pressures.
- What caused it? — answered by the ECG, evaluation for coronary disease, the blood panel, and sometimes cardiac MRI or genetic testing.
- How severe is it, and what else will affect treatment? — answered by the symptoms and functional class, the filling pressures, kidney function, and the other conditions a person carries.
No single test answers all four, which is why the workup combines them — and why one test can be normal while another is abnormal. The rest of this article walks through the main tests and what each contributes.
The Blood Test: Natriuretic Peptides
The most useful blood test in heart failure measures a natriuretic peptide — a hormone introduced in Article 1 as the heart’s own counter-signal. When the heart’s walls are stretched by rising pressure, the muscle releases these hormones into the blood, where they can be measured. The two forms used clinically are BNP (B-type natriuretic peptide) and NT-proBNP (a related fragment released alongside it). The more the heart is stretched, in general, the higher the level.[1]
What the test does best is rule the condition out. A low natriuretic peptide level substantially lowers the likelihood that heart failure is the cause of breathlessness, particularly in the outpatient setting — an NT-proBNP below roughly 125 picograms per milliliter, for instance, makes heart failure unlikely.[2] The exact cutoffs differ between the outpatient clinic and the emergency room, so a level means what it means only in the setting where it was measured. This is the test’s great strength: when it is low in someone with vague symptoms, it can spare them further cardiac testing and point attention elsewhere. A raised level supports the diagnosis in the right clinical setting and carries important prognostic information. Levels often shift as congestion and cardiac stress change, but they are read alongside everything else, not in isolation, and are not used as a simple treatment target.
What the test cannot do is prove heart failure on its own, because it is not specific to the heart. Natriuretic peptide levels climb with older age, with reduced kidney function, and with the irregular rhythm called atrial fibrillation, among other causes — so a raised value in an older person with kidney disease does not by itself confirm heart failure.[2][3]
There is also an important blind spot: excess body weight lowers natriuretic peptide levels. For reasons still being worked out, people carrying more weight tend to have lower readings than their hearts would otherwise produce, which means the test can read normal in someone whose heart is in fact failing.[3] This is not a rare technicality. A meaningful minority of people with preserved-ejection-fraction heart failure — the form most tied to obesity — have natriuretic peptide levels below the usual threshold despite clear heart failure on other testing.[1] The risk is that the test can be falsely reassuring in exactly the population most likely to have their heart failure overlooked. A normal result in someone with convincing, persistent symptoms is a reason not to dismiss heart failure outright — though what comes next depends on the whole clinical picture and how likely heart failure was to begin with, not on the number alone.
The natriuretic peptide is therefore most useful for ruling heart failure out, less useful for confirming it, and is always read alongside the clinical picture rather than in place of it.
At a glance:
| Blood test result | What it usually means | The catch |
| Low | Heart failure is unlikely | Can read falsely low with excess body weight — so in a convincingly symptomatic person, weigh it against the whole clinical picture rather than treating it as the final word |
| High | Supports heart failure in the right clinical setting, and carries prognostic information | Also rises with older age, reduced kidney function, and atrial fibrillation, so it does not confirm heart failure on its own |
The Ultrasound: The Echocardiogram
If the blood test raises or lowers suspicion, the echocardiogram is what shows the heart itself. It is an ultrasound scan — the same safe, radiation-free technology used in pregnancy — aimed at the heart, showing the chambers moving in real time. It is the central imaging test in heart failure, and usually the first imaging test ordered once heart failure is suspected.[1]
A single echocardiogram provides a great deal of information. It measures the ejection fraction — the percentage of blood the main chamber ejects with each beat — which sorts heart failure into the categories from Article 2. It shows the size of the chambers and the thickness of the walls, distinguishing a stretched, thin-walled heart from a thick, stiff one. It assesses the four valves, catching the narrowed or leaky valves that Article 3 identified as a cause. It evaluates the heart’s patterns of relaxation and filling — its diastolic function — and uses several indirect measurements to estimate whether the pressures inside are elevated, which is where much of preserved-ejection-fraction heart failure is found. And it looks at the right side of the heart, not just the left.
What the echocardiogram cannot do is also worth naming. It does not directly show blockages in the coronary arteries — that requires other tests. It cannot always reveal the underlying cause. And, as Article 2 stressed, the ejection fraction it produces is a useful measurement rather than an exact one, varying somewhat with who performs the scan and the conditions on the day. The assessment of diastolic function, in particular, can sometimes come back inconclusive, which is part of why preserved-ejection-fraction heart failure remains hard to confirm.
Why Ejection Fraction Shapes the Plan — but Is Only Part of the Picture
The ejection fraction deserves particular attention because it remains one of the measurements that most strongly shapes treatment — particularly the evidence for specific medications and devices. As Article 2 detailed, whether the ejection fraction is reduced or preserved has long determined which therapies have the strongest evidence behind them. That is why it is measured at diagnosis and re-measured over time — including to catch a pump that has recovered into the improved-ejection-fraction category. But the old picture, in which the ejection fraction sorted patients into completely separate therapeutic worlds, is softening: some treatments, the SGLT2 inhibitors most clearly, now help across the ejection-fraction range.
And yet it is only part of the picture. The ejection fraction captures the strength of the squeeze and nothing else. It says nothing about the pressures inside the heart, little about the cause, and, on its own, not enough about the trajectory. A person can have a perfectly normal ejection fraction and severe heart failure. Two people with the same ejection fraction can face very different futures depending on their symptoms, their filling pressures, their kidney function, and the conditions they carry. The ejection fraction is central to choosing treatment and insufficient for understanding the whole disease — which is precisely why it is read alongside the blood test, the symptoms, and everything below, never alone.
Finding the Cause, Not Just the Diagnosis
Confirming that someone has heart failure is only the first half of the job. The second — and often the more consequential — is finding out why, because, as Article 3 showed, the cause frequently determines whether the course can be changed.
This is where the rest of the workup comes in, and a typical evaluation draws on several tests, each answering a different question.
| Test | What it reveals | What it cannot do |
| Natriuretic peptide (BNP / NT-proBNP) | Whether the heart is under strain; strong at ruling heart failure out; carries prognostic information | Prove heart failure alone; can read high from age, kidney disease, or atrial fibrillation, and falsely low with obesity |
| Troponin (in acute presentations) | Injury to the heart muscle; helps flag a heart attack or acute cardiac stress | Point to a single cause — it rises in many conditions |
| Echocardiogram | Ejection fraction, chamber size, wall thickness, valve function, and an estimate of the filling pressures | Show coronary blockages directly; always identify the cause |
| Electrocardiogram (ECG) | The heart’s rhythm and electrical patterns; signs of past heart attack or strain | Measure pump strength directly |
| Chest X-ray | Fluid in the lungs, an enlarged heart | Detail the cause; it can be normal despite heart failure, so it cannot establish the diagnosis alone |
| Blood panel | Blood count, kidney and liver function, electrolytes, glucose, thyroid, and iron — conditions that cause or worsen heart failure, or affect which treatments are safe | Confirm heart failure itself |
| Evaluation for coronary disease | Whether blocked arteries are contributing; chosen to fit the situation — CT coronary angiography, stress imaging, or invasive angiography | Be treated as a single routine test — CT, stress imaging, and invasive angiography answer somewhat different questions |
| Cardiac MRI | Detailed muscle structure; can identify specific causes such as infiltration, inflammation, or amyloidosis | Not part of the routine workup; less widely available, and reserved for selected cases |
The blood panel deserves a word, because it does double duty. Routine blood testing commonly evaluates blood count, kidney and liver function, electrolytes, glucose control, thyroid function, and iron status — all things that can cause or worsen heart failure, and all things that shape which treatments are safe.[2] Where the cause remains unclear — or where a specific muscle disease is suspected — cardiac MRI can characterize the heart tissue in ways ultrasound cannot, helping identify treatable causes such as cardiac amyloidosis or inflammation.[5] Where an inherited muscle disease is suspected, genetic testing can pin down a specific cause and open the door to screening relatives before they ever develop symptoms.[5] And when even careful testing leaves preserved-ejection-fraction heart failure in doubt, clinicians may turn to exercise testing or to direct measurement of the pressures inside the heart, which can reveal congestion that only appears under the stress of activity.[1]
The Hard Case: Preserved-Ejection-Fraction Heart Failure
Everything that makes preserved-ejection-fraction heart failure hard to treat, from Article 2, also makes it hard to diagnose: a normal natriuretic peptide does not exclude it, and the echocardiogram can look unremarkable at rest. The reason is worth understanding. Some people have normal pressures inside the heart while they are sitting still, and develop abnormal rises in filling pressure only during exertion — which is exactly when they feel breathless. That is why a normal resting echocardiogram and a low blood test do not always settle the question when the symptoms and clinical suspicion remain convincing, and why confirming it can take scoring systems, exercise testing, or direct measurement of the pressures during activity.[1][4] The form of heart failure that is hardest to treat is also, for related reasons, the hardest to diagnose.
Following Heart Failure Over Time
Testing in heart failure is not a one-time event — but it is not endless routine surveillance either. It continues as clinically needed. Blood tests are often repeated during medication adjustment, because several heart failure drugs require watching kidney function and electrolytes as doses are changed — the careful titration that Article 6 describes. Natriuretic peptides may be repeated when the result will help answer a specific question. And the echocardiogram is repeated when a change in symptoms or treatment, or an upcoming decision such as device eligibility, makes reassessment useful — for example, to check whether the ejection fraction has improved with treatment. Diagnosis is the beginning; the testing that follows is guided by what will change the plan.
Clinical Bottom Line
Heart failure is confirmed not by one test but by a convergence of them — the clinical picture, a natriuretic peptide blood test, and an echocardiogram — each covering the others’ blind spots. The blood test is best at ruling heart failure out, but it climbs with age, kidney disease, and atrial fibrillation, and reads falsely low with excess weight, so a normal result in a convincingly symptomatic person is weighed against the whole clinical picture rather than taken as the final word. The echocardiogram shows the heart directly and provides the ejection fraction — one of the measurements that most shapes treatment, though modern therapy increasingly reaches across ejection-fraction categories, and a normal value never rules heart failure out. Beyond confirming the diagnosis, the workup aims to find the cause, because the cause often determines what can be done. And testing continues as clinically needed, guiding treatment as the condition evolves.
What Comes Next
This article covered how heart failure is confirmed and followed. Article 6 turns to treatment — the four classes of medication that now change the course of reduced-ejection-fraction heart failure, why the combination matters more than any single drug, why doses are carefully adjusted toward evidence-based targets, and why some of these medicines protect the heart without making a person feel any different from day to day.
Key Terms
Clinical syndrome: A recognizable pattern of symptoms and signs that occur together and are confirmed by objective testing, rather than a single laboratory value.
Natriuretic peptide: A hormone the heart releases when its walls are stretched by rising pressure; measured in blood to help evaluate suspected heart failure and provide prognostic information. Levels may also be repeated when they help answer a specific clinical question.
BNP (B-type natriuretic peptide): One form of natriuretic peptide measured in blood testing.
NT-proBNP: A related fragment released with BNP, measured in the same way; interpreted using different numeric thresholds.
Ruling out: Using a test result to make a condition unlikely; a low natriuretic peptide is especially good at ruling heart failure out.
Echocardiogram: An ultrasound scan of the heart — safe and radiation-free — that shows the chambers moving and measures the ejection fraction.
Ejection fraction: The percentage of blood the main chamber ejects with each beat; sorts heart failure into treatment categories but does not, by itself, capture the whole disease.
Diastolic function: How well the heart relaxes and fills between beats; often impaired in preserved-ejection-fraction heart failure and sometimes difficult to assess.
Filling pressures: The pressures inside the heart as it fills; when elevated, they drive congestion, and they can sometimes be measured directly when the diagnosis is unclear.
Electrocardiogram (ECG): A recording of the heart’s electrical activity, showing rhythm and signs of past injury or strain.
Cardiac MRI: A detailed magnetic-resonance scan of the heart muscle, able to identify specific causes such as infiltration, inflammation, or amyloidosis.
Coronary angiography: A test that visualizes blockages in the arteries supplying the heart muscle.
References
- Walsh MN, Kober L, Sliwa K, et al. AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026). Circulation. 2026;153. https://doi.org/10.1161/CIR.0000000000001455
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895–e1032. https://doi.org/10.1161/CIR.0000000000001063
- Taylor CJ, Taylor KS, Jones NR, et al. Age-adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: diagnostic accuracy study. ESC Heart Fail. 2025;12(5):3552–3568. https://doi.org/10.1002/ehf2.15383
- Redfield MM, Borlaug BA. Heart Failure With Preserved Ejection Fraction: A Review. JAMA. 2023;329(10):827–838. https://doi.org/10.1001/jama.2023.2020
- Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC Guidelines for the Management of Cardiomyopathies. Eur Heart J. 2023;44(37):3503–3626. https://doi.org/10.1093/eurheartj/ehad194
HeartBuddi • Your heart. Own it.